GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma

Overview of attention for article published in Journal of Hepatology, June 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

blogs: 1 blog
patent: 21 patents

guideline: 2 clinical guideline sources

Readers on

mendeley: 83 Mendeley

So far, Altmetric has seen 21 patents that reference this research output.

Anti-GP73 monoclonal antibodies and methods of obtaining the same

Grant US-11421023-B2

United States of America

23 Aug 2022

ANTI-GP73 ANTIBODIES AND IMMUNOCONJUGATES

Application EP-4015532-A1

European Patent Office

22 Jun 2022

ANTI-GOLPH2 ANTIBODIES FOR MACROPHAGE AND DENDRITIC CELL DIFFERENTIATION

Application WO-2022043517-A2

World Intellectual Property Organisation (WIPO)

03 Mar 2022

Diagnosis of liver pathology through assessment of protein glycosylation

Grant US-10823740-B2

United States of America

03 Nov 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 17 additional patents.